OPEN END TURBO PUT WARRANT - AMGEN | Delayed Deutsche Boerse AG 18:36:58 07/06/2024 BST | ||
| 0.86 EUR | +2.38% |
|
| 3 months | -27.12% | ||
| 6 months | -28.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 0.86 | +2.38% |
| 06/06/24 | 0.84 | +1.20% |
| 05/06/24 | 0.83 | 0.00% |
| 04/06/24 | 0.83 | -2.35% |
| 03/06/24 | 0.85 | -1.16% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 06:36 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK9NFF |
| ISIN | DE000UK9NFF3 |
| Date issued | 10/11/2022 |
| Strike | 398.9 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.23 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.81 € |
|---|---|
| Lowest since issue | 0.7 € |
| Spread | 0.1 € |
| Spread % | 10.87% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
